CanniMed Therapeutics Inc CEO Responds to Hostile Takeover Bid From Aurora Cannabis Inc.
Brent Zettl CEO of CanniMed Therapeutics Inc. talks to James about the hostile takeover now underway by Aurora Cannabis Inc. Brent shares his side of the story and argues why his shareholders should stay with the company and not tender their shares to Aurora. He also discusses CanniMed's interest in Newstrike Resources Ltd, and how that could affect this volatile situation.
December 13, 2017 By James West Midas Letter
Source: Midas Letter Live
Print this page